TASSI: Norme per il diritto di brevetto dei prodotti medicinali

This procedure concerns the rules for patent law related to medicinal products. It aims to clarify and potentially update the legal framework governing the patentability and protection of pharmaceutical innovations within Italy. The changes will affect pharmaceutical companies, researchers, and patients by influencing the availability and cost of medicines. It ensures alignment with EU standards and national patent legislation.